Teladoc Health PE Ratio 2014-2024 | TDOC
Current and historical p/e ratio for Teladoc Health (TDOC) from 2014 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Teladoc Health PE ratio as of November 05, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Teladoc Health PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-11-05 | 9.15 | 0.00 | |
| 2024-09-30 | 9.18 | $-5.77 | 0.00 |
| 2024-06-30 | 9.78 | $-5.93 | 0.00 |
| 2024-03-31 | 15.10 | $-1.41 | 0.00 |
| 2023-12-31 | 21.55 | $-1.34 | 0.00 |
| 2023-09-30 | 18.59 | $-24.66 | 0.00 |
| 2023-06-30 | 25.32 | $-24.76 | 0.00 |
| 2023-03-31 | 25.90 | $-43.58 | 0.00 |
| 2022-12-31 | 23.65 | $-84.74 | 0.00 |
| 2022-09-30 | 25.35 | $-61.32 | 0.00 |
| 2022-06-30 | 33.21 | $-61.40 | 0.00 |
| 2022-03-31 | 72.13 | $-43.04 | 0.00 |
| 2021-12-31 | 91.82 | $-2.77 | 0.00 |
| 2021-09-30 | 126.81 | $-5.77 | 0.00 |
| 2021-06-30 | 166.29 | $-5.67 | 0.00 |
| 2021-03-31 | 181.75 | $-5.15 | 0.00 |
| 2020-12-31 | 199.96 | $-4.24 | 0.00 |
| 2020-09-30 | 219.24 | $-1.43 | 0.00 |
| 2020-06-30 | 190.84 | $-1.28 | 0.00 |
| 2020-03-31 | 155.01 | $-1.35 | 0.00 |
| 2019-12-31 | 83.72 | $-1.38 | 0.00 |
| 2019-09-30 | 67.72 | $-1.47 | 0.00 |
| 2019-06-30 | 66.41 | $-1.53 | 0.00 |
| 2019-03-31 | 55.60 | $-1.52 | 0.00 |
| 2018-12-31 | 49.57 | $-1.48 | 0.00 |
| 2018-09-30 | 86.35 | $-1.89 | 0.00 |
| 2018-06-30 | 58.05 | $-2.10 | 0.00 |
| 2018-03-31 | 40.30 | $-1.98 | 0.00 |
| 2017-12-31 | 34.85 | $-1.89 | 0.00 |
| 2017-09-30 | 33.15 | $-1.44 | 0.00 |
| 2017-06-30 | 34.70 | $-1.54 | 0.00 |
| 2017-03-31 | 25.00 | $-1.64 | 0.00 |
| 2016-12-31 | 16.50 | $-1.74 | 0.00 |
| 2016-09-30 | 18.31 | $-1.82 | 0.00 |
| 2016-06-30 | 16.02 | $-1.52 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.575B | $2.602B |
| Teladoc Health, Inc. provides virtual access to high-quality care and expertise with a portfolio of services and solutions, covering medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company combines the latest in data and analytics with an award-winning user experience through a highly flexible technology platform. The company provides access to healthcare through its portfolio of five consumer brands 24 hours a day, seven days a week and 365 days a year. Its solutions are delivered with an approximate median response time of less than ten minutes in the United States for general medical inquiries from the time a member requests a general medical telehealth visit to the time they consult with a Teladoc Health network provider. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $96.890B | 12.02 |
| Cencora (COR) | United States | $46.107B | 17.62 |
| DiDi Global (DIDIY) | China | $23.233B | 0.00 |
| ICON (ICLR) | Ireland | $18.679B | 16.64 |
| Revvity (RVTY) | United States | $15.535B | 26.63 |
| Avantor (AVTR) | United States | $15.498B | 23.24 |
| Natera (NTRA) | United States | $15.385B | 0.00 |
| Viatris (VTRS) | United States | $13.858B | 4.22 |
| BioMerieux (BMXMF) | France | $13.601B | 0.00 |
| Solventum (SOLV) | United States | $12.636B | 0.00 |
| CochLear (CHEOY) | Australia | $12.565B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.202B | 28.74 |
| Charles River Laboratories (CRL) | United States | $9.742B | 18.41 |
| Sonic Healthcare (SKHHY) | Australia | $8.273B | 0.00 |
| HealthEquity (HQY) | United States | $7.792B | 42.29 |
| Doximity (DOCS) | United States | $7.787B | 49.34 |
| Bausch + Lomb (BLCO) | Canada | $6.975B | 32.47 |
| Life Times (LTH) | United States | $4.762B | 31.52 |
| PACS (PACS) | United States | $4.502B | 0.00 |
| Sotera Health (SHC) | United States | $4.367B | 23.36 |
| Organon (OGN) | United States | $4.239B | 4.28 |
| Surgery Partners (SGRY) | United States | $3.778B | 41.86 |
| BrightSpring Health Services (BTSG) | United States | $3.070B | 65.30 |
| Ardent Health Partners (ARDT) | United States | $2.577B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.546B | 0.00 |
| Concentras Parent (CON) | United States | $2.480B | 0.00 |
| Premier (PINC) | United States | $2.271B | 11.34 |
| GoodRx Holdings (GDRX) | United States | $2.254B | 84.86 |
| GeneDx Holdings (WGS) | United States | $2.057B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.507B | 7.57 |
| Progyny (PGNY) | United States | $1.425B | 25.06 |
| Establishment Labs Holdings (ESTA) | $1.338B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.319B | 12.91 |
| CareDx (CDNA) | United States | $1.228B | 0.00 |
| Agilon Health (AGL) | United States | $1.123B | 0.00 |
| Embecta (EMBC) | United States | $0.864B | 5.76 |
| InnovAge Holding (INNV) | United States | $0.822B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| SBC Medicals (SBC) | United States | $0.722B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.488B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.483B | 0.00 |
| Enhabit (EHAB) | United States | $0.382B | 33.04 |
| DocGo (DCGO) | United States | $0.355B | 13.35 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.309B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.255B | 0.00 |
| ModivCare (MODV) | United States | $0.232B | 7.37 |
| Beauty Health (SKIN) | United States | $0.211B | 0.00 |
| Biodesix (BDSX) | United States | $0.195B | 0.00 |
| LifeMD (LFMD) | United States | $0.192B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.178B | 0.00 |
| MultiPlan (MPLN) | United States | $0.136B | 0.00 |
| Nutex Health (NUTX) | United States | $0.127B | 0.00 |
| So-Young (SY) | China | $0.092B | 22.35 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.059B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.057B | 0.00 |
| OncoCyte (OCX) | United States | $0.049B | 0.00 |
| NeueHealth (NEUE) | United States | $0.041B | 1.63 |
| Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.036B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| Oncology Institute (TOI) | United States | $0.021B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| KindlyMD (KDLY) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |